ACIU — AC Immune SA

—
Nasdaq · Health Care · Pharmaceuticals · CIK 1651625 ·
Last close
$2.11
Market Cap
$209.79M
52W High
$3.90
52W Low
$2.02
ADV30
193,328
Next earnings
2026-11-04

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 3,244,000 — -9,801,000 -8,750,000 139,208,000 18,726,000 112,264,000
Jun 2026 15,113,000 — 1,193,000 1,874,000 150,401,000 27,757,000 115,232,000
Mar 2026 1,119,000 — -14,788,000 -14,801,000 137,421,000 19,169,000 105,887,000
Dec 2025 338,000 — -14,406,000 -14,373,000 154,251,000 26,795,000 109,367,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-69,262,000
Investing CF
$63,542,000
Financing CF
$-1,020,000
CapEx
$-900,000
Dividends Paid
—
Buybacks
$-5,000
EPS Diluted TTM
$-0.65
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$-459,254,000
Inventory
—
Receivables
$4,063,000
ST Investments
$55,186,000
EBIT TTM
$-35,823,000
Pretax Income TTM
$-36,050,000
Interest Exp TTM
$227,000
Analysts
4

Yahoo Snapshot (yfinance, live)

Total Revenue
$17,509,000
EBITDA
$-42,479,000
Free Cash Flow
$-33,138,624
Enterprise Value
$203,163,328
Total Cash
$75,357,000
Total Debt
$4,102,000
Shares Out
99,426,932
Trailing EPS
$-0.53
Book Value
$0.44
ROE
-78.5%
ROA
-16.0%
Div Yield
—

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 3,573,000 -68,863,000 -70,447,000 154,251,000 109,367,000 44,884,000 -69,262,000
Dec 2024 27,309,000 -52,378,000 -50,916,000 230,913,000 118,643,000 112,270,000 65,842,000
Dec 2023 14,801,000 -53,624,000 -54,233,000 182,814,000 22,171,000 160,643,000 -60,408,000
Dec 2022 3,935,000 -70,847,000 -70,753,000 185,938,000 16,947,000 168,991,000 -73,568,000

TTM Snapshot

Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$0.60

Max Pain — expiry 2026-12-18 (volume-derived — Yahoo OI feed degraded)

max pain strike: $2.50 · spot: $2.10 · call volume: 90 · put volume: 1
Expected Move to 2026-12-18: ±$0.68 (32.38%) — implied range $1.42 – $2.78 · ATM straddle on $2.50 strike

Peers — same industry

TickerNameMarket CapLastDaily %
NGEN NERVGEN PHARMA CORP. $210.74M $1.96 —
LAB STANDARD BIOTOOLS INC. $212.95M $0.54 —
CYPH CYPHERPUNK TECHNOLOGIES INC. $205.29M $1.90 —
PRLD Prelude Therapeutics Inc $216.05M $3.32 —
DRUG BRIGHT MINDS BIOSCIENCES INC. $201.25M $20.51 —

News headlines (Yahoo Finance, 1h cache)

AC Immune to Present at Jefferies Global Healthcare Conference 2026
2026-11-11 12:00 · Yahoo
AC Immune (ACIU) Reports Q3 Loss, Beats Revenue Estimates
2026-11-04 12:55 · Yahoo
AC Immune: Q3 Earnings Snapshot
2026-11-04 12:25 · Yahoo
AC Immune Third Quarter 2026 Financial and Corporate Update
2026-11-04 12:00 · Yahoo
Ionis' Tryngolza Gets EU Approval for Severe Hypertriglyceridemia
2026-11-18 16:34 · Yahoo
GSK Wins FDA Approval for Nuvalent-Acquired Nelkarmi in Lung Cancer
2026-11-18 15:35 · Yahoo
Xenon Stock Rises 12% in the Past Month on Pipeline Progress
2026-11-17 15:11 · Yahoo
Summit Stock Falls on FDA Rejection for Lung Cancer Drug
2026-11-16 16:13 · Yahoo
Kodiak Q3 Loss Wider Than Expected, Pipeline Development in Focus
2026-11-13 15:41 · Yahoo
CRMD Stock Down 9% Despite Q3 Earnings and Revenues Beat Estimates
2026-11-13 13:20 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.